Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol

201095 citationsJournal Article

Authors

Richard Pavkov · Novartis (United States)

Stefan Müeller · Novartis (Switzerland)

Katrin Fiebich · Novartis (Switzerland)

Dilraj Singh · Novartis (Switzerland)

Frank Stowasser · Novartis (Switzerland)

Giovanni Pignatelli · Novartis (Switzerland)

Benoît Walter ·

Abstract

The capsule based DPI device is a low resistance device, suitable for use by patients with a wide range of COPD severities, delivering a consistent dose irrespective of disease severity and age. The device provided consistent delivery of indacaterol with no reported device failures in clinical trials.

Topics & Keywords

Inhalation and Respiratory Drug Delivery Asthma and respiratory diseases Chronic Obstructive Pulmonary Disease (COPD) Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Current Medical Research and Opinion

Volume 26, Issue 11, pp. 2527-2533

DOI: 10.1185/03007995.2010.518916

Field-Weighted Citation Impact: 4.69